Cold Agglutinin Disease News
WEBSep 23, 2024 — Cold agglutinin disease (CAD) is a rare disorder in which the immune system mistakenly attacks red blood cells, resulting in anemia. Discover. Causes. CAD is characterized by autoantibodies, called cold agglutinins, binding to and activating the destruction of red blood cells when exposed to cold temperatures. Explore.
Sanofi Drug for Rare Blood Disease Is Heading to Recordati for …
WEB1 day ago — In these three markets, the companies estimate cold agglutin disease affects between 11,000 and 12,000 patients. Recordati, which is headquartered in Milan, is the latest stop in a long journey ...
Sanofi Offloads Rare Autoimmune Drug to Recordati in ... - BioSpace
WEB17 hours ago — Sanofi sold Enjaymo, its humanized monoclonal antibody treatment for the rare autoimmune disorder cold agglutinin disease, to Italy’s Recordati in an agreement potentially worth more than $1 billion. Under the terms of the deal, Milan-based Recordati will pay $825 million upfront and will pledge up to $250 million in sales-based milestones.
Latest NEWS-articles-Videos - Cold Agglutinin Disease Foundation
WEBCold agglutinin disease: current challenges and future prospectssk for Lymphoma. Learn more.
In sustained rare disease push, Recordati lays out $825M upfront …
WEB16 hours ago — Recordati is floating $825 million upfront—plus another $250 million in potential commercial milestones—to get its hands on the global rights to Sanofi’s rare disease biologic Enjaymo.
Sanofi Sells Global Rights To Rare Autoimmune Drug Enjaymo For …
WEB15 hours ago — Enjaymo, a humanized monoclonal antibody, is the only approved targeted product for cold agglutinin disease (CAD), a rare autoimmune disorder characterized by the premature destruction of red ...
What is cold agglutinin disease? - Medical News Today
WEBMay 30, 2024 — What is cold agglutinin disease? Read on to learn about this rare type of autoimmune hemolytic anemia, including its causes, symptoms, and treatments.
Cold Agglutinin Disease: New Direction for an Old Disease
WEBApr 28, 2023 — We start the series off with an article from Drs. Surbhi Shah and Ronald Go, who provide a detailed overview of cold agglutinin disease, an uncommon but serious disorder that can be a challenging diagnosis, and the potential treatment options.
Treatment of Cold Agglutinin Disease | ASH Clinical News
WEBSigbjørn Berentsen, MD, PhD, discusses the diagnosis and management of cold agglutinin disease, a rare subtype of autoimmune hemolytic anemia. This material is repurposed from “How I treat cold agglutinin disease,” published in the March 11, 2021, edition of Blood.
FDA approves treatment for adults with rare type of anemia
WEBFeb 4, 2022 — FDA has approved Enjaymo (sutimlimab-jome) infusion to decrease the need for red blood cell transfusion due to hemolysis (red blood cell destruction) in adults with cold agglutinin disease (CAD).